Actively Recruiting
A Study of GZR4 Injection at Different Injection Sites
Led by Gan and Lee Pharmaceuticals, USA · Updated on 2024-08-12
24
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial is conducted in China. This study is a randomized, single-center, open, three-period crossover trial in healthy subjects to compare the PK, PD, and safety of a single administration of GZR4 at different injection sites (abdomen, deltoid region of upper arm, and thigh).
CONDITIONS
Official Title
A Study of GZR4 Injection at Different Injection Sites
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male adults aged 18 to 55 years
- Body mass index (BMI) between 19.0 and 24.0 kg/m2
- Signed informed consent form and able to comply with study requirements
You will not qualify if you...
- Known or suspected hypersensitivity to the investigational product or related products
- Participation in another clinical drug study within 3 months before randomization
- Abnormal findings in physical exam, vital signs, lab tests, imaging, or ECG with clinical significance
- Blood donation over 100 mL or significant blood loss over 200 mL within 6 months before screening
- Consumption of more than 14 units of alcohol per week within 3 months before randomization
- Smoking more than 5 cigarettes per day within 3 months before randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Study Site
Beijing, China
Actively Recruiting
Research Team
W
wei zhao, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here